Cytosorbents (CTSO) news
Recent news
Cytosorbents Q2 adjusted EPS USD -0.05
CytoSorbents Corporation (NASDAQ: CTSO) reported an adjusted earnings per share (EPS) of -$0.05 for the second quarter of 2023, reflecting continued operational and financial challenges for the company. The adjusted EPS represents a slight improvement compared to the prior year period, where the…
AInvest Wire · Aug 6, 2026Cytosorbents to report second quarter 2026 financial results and recent business highlights
AInvest Wire · Jul 20, 2026CytoSorbents to Report Q4 and FY25 Earnings on March 25
• CytoSorbents to report Q4 and FY25 results on March 25, 2026. • Webcast to be hosted at 4:30 PM ET. • Results and discussion to be live streamed on the company's website. • Archived recording available on the website after the event.
AInvest Wire · Mar 5, 2026ImportantCytosorbents shares lost nearly 23% in premarket trading after Star-T study failed to secure primary effectiveness endpoint.
Cytosorbents shares lost nearly 23% in premarket trading after Star-T study failed to secure primary effectiveness endpoint. Cytosorbents Corporation, a company specializing in blood purification technology, experienced a significant drop in premarket trading after its STAR-T study failed to meet…
AInvest Wire · Dec 28, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.